glp 1 mimetic Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus Frontiers | Mechanisms of action
Description
Health secretary pick advocates lifestyle changes first, but softens previous criticism of popular medications
If you've struggled to lose weight, a GLP-1 drug could be the solution
Yet what happens after someone starts taking them receives far less attention
Och A, Och M, Nowak R, Podgrska D, Podgrski R
Health Canada authorizes injection for treatment of adult patients with type 2 diabetes
Pharmacological inhibition of the NLRP3 inflammasome suppressed PFKFB3-driven glycolysis and vice versa, resulting in decreased lactate production in TGF-1+IL-1-stimulated lung fibroblasts
